City Therapeutics, Inc. Common Stock Market Cap ($911.01 Million)

$911.01 Million USD  · Rank #9050

Market Cap & Net Worth: City Therapeutics, Inc. Common Stock (CTY)

City Therapeutics, Inc. Common Stock market cap. City Therapeutics, Inc. Common Stock (NASDAQ:CTY) has a market capitalization of $911.01 Million ($911.01 Million) as of November 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9050 globally and #2589 in its home market, demonstrating a 6.03% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying City Therapeutics, Inc. Common Stock's stock price $18.10 by its total outstanding shares 50332279 (50.33 Million). Also see how efficiently does City Therapeutics, Inc. Common Stock generate cash for how efficiently the company converts equity into cash flow.

City Therapeutics, Inc. Common Stock Market Cap History (2026–2026)

City Therapeutics, Inc. Common Stock market cap history from 2026 to 2026. Data shows growth from $911.01 Million to $911.01 Million (0.00% CAGR). Check City Therapeutics, Inc. Common Stock (CTY) share price today for real-time trading data and today's change.

City Therapeutics, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how City Therapeutics, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore City Therapeutics, Inc. Common Stock annual equity growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of CTY by Market Capitalization

Companies near City Therapeutics, Inc. Common Stock in the global market cap rankings as of November 16, 2026. Also see City Therapeutics, Inc. Common Stock total assets for a full breakdown of the balance sheet.

Key companies related to City Therapeutics, Inc. Common Stock by market ranking:

  • Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
  • Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #286 globally with a market cap of $93.55 Billion USD.
  • Moderna Inc (NASDAQ:MRNA): Ranked #304 globally with a market cap of $90.38 Billion USD.
  • CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $69.66 Billion USD ( AU$98.45 Billion AUD).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#180 Vertex Pharmaceuticals Inc NASDAQ:VRTX $130.90 Billion $538.60
#286 Regeneron Pharmaceuticals Inc NASDAQ:REGN $93.55 Billion $955.47
#304 Moderna Inc NASDAQ:MRNA $90.38 Billion $223.37
#412 CSL Ltd AU:CSL $69.66 Billion AU$202.92

Market Capitalization of City Therapeutics, Inc. Common Stock (2026–2026)

Market capitalization of City Therapeutics, Inc. Common Stock from 2026 to today. Between 2026 and today, City Therapeutics, Inc. Common Stock's market cap moved from $911.01 Million to $ 911.01 Million, with a yearly change of 0.00%.

Year Market Cap Change (%)
2026 $911.01 Million --

End of Day Market Cap According to Different Sources

On Nov 15th, 2026 the market cap of City Therapeutics, Inc. Common Stock was reported to be:

Source Market Cap
Yahoo Finance $911.01 Million USD
MoneyControl $911.01 Million USD
MarketWatch $911.01 Million USD
marketcap.company $911.01 Million USD
Reuters $911.01 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About City Therapeutics, Inc. Common Stock

NASDAQ:CTY USA Biotechnology
Market Cap
$911.01 Million
Market Cap Rank
#9050 Global
#2589 in USA
Share Price
$18.10
Change (1 day)
-4.64%
52-Week Range
$16.41 - $22.14
All Time High
$22.14
About

City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineering RNAi trigger molecules. The company develops RNAi-based medicines using engineered small interfering RNAs (siRNAs) and is building a pipeline of therapeutics targeting diseases across multiple therapeutic areas, including ophthalmologic conditions such as re… Read more